Amebic meningoencephalitides and keratitis: challenges in diagnosis and treatment.
about
Primary amoebic meningoencephalitis in an Iranian infantAn update on Acanthamoeba keratitis: diagnosis, pathogenesis and treatmentStructure and function of a unique pore-forming protein from a pathogenic acanthamoebaPhylogenetic analysis of mitochondrial outer membrane β-barrel channels.Disseminated Balamuthia mandrillaris Infection.Corifungin, a new drug lead against Naegleria, identified from a high-throughput screen.Twenty years of acanthamoeba diagnostics in AustriaBis-benzimidazole hits against Naegleria fowleri discovered with new high-throughput screens.Balamuthia mandrillaris and Acanthamoeba amebic encephalitis with neurotoxoplasmosis coinfection in a patient with advanced HIV infection.Emerging Threats for Human Health in Poland: Pathogenic Isolates from Drug Resistant Acanthamoeba Keratitis Monitored in terms of Their In Vitro Dynamics and Temperature AdaptabilityOcular parasitoses and their immunology.EFNS-ENS guidelines for the use of PCR technology for the diagnosis of infections of the nervous system.Parasitoses of the human central nervous system.Atypical ulcers.Pore-forming toxins from pathogenic amoebae.In vitro efficacy of corifungin against Acanthamoeba castellanii trophozoites and cysts.Amebicidal activity of the essential oils of Lippia spp. (Verbenaceae) against Acanthamoeba polyphaga trophozoites.Miltefosine and polyhexamethylene biguanide: a new drug combination for the treatment of Acanthamoeba keratitis.Evaluation of Acanthamoeba myosin-IC as a potential therapeutic target.Larrea tridentata: A novel source for anti-parasitic agents active against Entamoeba histolytica, Giardia lamblia and Naegleria fowleri.Potent antimicrobial peptides against Legionella pneumophila and its environmental host, Acanthamoeba castellanii.The cyclic AMP phosphodiesterase RegA critically regulates encystation in social and pathogenic amoebasThe social amoeba Polysphondylium pallidum loses encystation and sporulation, but can still erect fruiting bodies in the absence of cellulose.Cytotoxic effect of acriflavine against clinical isolates of Acanthamoeba spp.Effect of combined chlorhexidine gluconate and neosporin on experimental keratitis with two pathogenic strains of Acanthamoeba.In Vitro Efficacy of Ebselen and BAY 11-7082 Against Naegleria fowleri.Identification of cysteine protease inhibitors as new drug leads against Naegleria fowleri.Evaluation of the activity of new cationic carbosilane dendrimers on trophozoites and cysts of Acanthamoeba polyphaga.In-vitro Activity of Trigonella foenum graecum Seeds Against a Clinical Strain of Acanthamoeba Genotype T4.Primary Amebic Meningoencephalitis.AcanthamoebaXenic Cultivation and Genotyping of Pathogenic Free-Living Amoeba from Public Water Supply Sources in Uganda
P2860
Q21284975-33D79FCB-9540-40E9-86C0-CEE70A74EF23Q22812999-83B5F068-7EC1-4E0F-9E45-50F76749188DQ27683389-2F368511-47FB-46BC-9664-DB697A76CDC9Q30155409-C2C15AFE-F190-464D-A56F-A0209C9900C0Q30279076-BD51808F-DE61-41E2-861B-9655860F2B5EQ34368425-0ABE2090-53AE-4537-82D2-5FE096E42661Q35127597-1F6A95F2-86AA-4F23-BC93-4F1222289CFFQ35169050-52A3ACB2-DF9A-4093-A69F-9F9BCB554D17Q35806882-43C6DCC3-153B-4DAA-8B14-6AE4D94E93D3Q35872801-EB21E867-2ECD-4099-AD29-581490C5B820Q37959537-8AB549C5-5D57-4FCB-BC49-529634B7F33CQ38033652-A94C1A61-29C0-4E72-89B3-F3A817B72EEAQ38050556-F7F3664C-B4E6-4CE7-B005-AC3EF92C6F4FQ38112476-B80FECF9-024E-4811-AF82-67FC5B3FF262Q38199998-51E9E710-88DB-49F9-955F-86F370219F3BQ38325869-1CFD9F42-3AAD-49B7-BB91-DC845CA221FEQ38829656-60A977F1-DB21-45DC-87B3-8A7EA4719958Q39163677-9A11606D-F96B-4BB4-BF55-5246B5B88C42Q39220506-59AD9936-C61C-4DDE-89C8-6DF64DFF6FEAQ40100127-70B12246-2497-4DB0-80B1-E1EFAB164D80Q41577063-C1A8A503-2990-46EB-AB6C-A325244EA8EAQ41899564-C92763E6-DA1F-4E14-A970-AB14FBC1CEFDQ42016988-A79C0C63-0976-4D6F-B4B0-DE107A674479Q45259980-F42747E5-C4F1-4D66-8C02-12E1AC724BDAQ51173609-EFB8F37E-9589-4469-B49F-D9AAD21DF1B3Q52645932-BD624CA6-CCBD-4756-915E-C30AC0701051Q52650006-98D69296-133F-4BB9-9C2D-53F369EE9247Q52654699-4F308036-50CE-49BD-84F4-B9934042A2CCQ54940244-00B989D4-F186-4764-8526-993E4AFA8C38Q55619119-8509B3F9-BE7E-4A7A-BBD5-0EE53798C616Q58493539-14CC95D4-6F66-46F6-B349-99C326117522Q58863093-1590654D-EED8-4CBB-8406-5D3E37B16188
P2860
Amebic meningoencephalitides and keratitis: challenges in diagnosis and treatment.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Amebic meningoencephalitides and keratitis: challenges in diagnosis and treatment.
@en
Amebic meningoencephalitides and keratitis: challenges in diagnosis and treatment.
@nl
type
label
Amebic meningoencephalitides and keratitis: challenges in diagnosis and treatment.
@en
Amebic meningoencephalitides and keratitis: challenges in diagnosis and treatment.
@nl
prefLabel
Amebic meningoencephalitides and keratitis: challenges in diagnosis and treatment.
@en
Amebic meningoencephalitides and keratitis: challenges in diagnosis and treatment.
@nl
P1476
Amebic meningoencephalitides and keratitis: challenges in diagnosis and treatment.
@en
P2093
Govinda S Visvesvara
P304
P356
10.1097/QCO.0B013E32833ED78B
P577
2010-12-01T00:00:00Z